Bunker Kevin D.
SEC CIK 1807484 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | CSO | 834.9K | — | $13.79M | 34 | 2021-07-01 | 2023-12-20 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Bunker Kevin D. made no open-market trades at ZNTL in the last 12 months.
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-21 | 2023-12-20 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | G - Gift | $0.00 | -24.2K | 834.9K | -3% | $0 | |
| M | 2023-10-06 | 2023-10-04 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | S - Sale | $19.51 | -6,068 | 860.1K | -0.7% | -$118.4K |
| I | 2023-05-31 | 2023-05-26 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | S - Sale | $30.02 | -80.0K | 15.0K | -84% | -$2.40M |
| M | 2023-02-14 | 2023-02-13+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | S - Sale | $20.14 | -10.3K | 865.2K | -1% | -$207.6K |
| D | 2023-02-01 | 2023-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | A - Grant | $0.00 | +91.4K | 875.5K | +12% | $0 |
| D | 2023-02-01 | 2022-11-09 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | G - Gift | $0.00 | -30.0K | 784.1K | -4% | $0 |
| D | 2022-10-03 | 2022-10-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | CSO | A - Grant | $0.00 | +50.0K | 814.1K | +7% | $0 |
| I | 2022-08-12 | 2022-08-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $30.00 | -5,000 | 95.0K | -5% | -$150.0K |
| I | 2022-07-20 | 2022-07-20 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $30.00 | -5,000 | 100.0K | -5% | -$150.0K |
| MI | 2022-07-14 | 2022-07-13+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $30.01 | -5,000 | 105.0K | -5% | -$150.1K |
| I | 2022-07-06 | 2022-07-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $30.07 | -25.0K | 110.0K | -19% | -$751.8K |
| MI | 2022-04-13 | 2022-04-11 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $30.55 | -5,000 | 135.0K | -4% | -$152.7K |
| MI | 2022-03-21 | 2022-03-21 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $49.07 | -10.0K | 140.0K | -7% | -$490.7K |
| MI | 2022-03-10 | 2022-03-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $46.94 | -10.0K | 151.7K | -6% | -$469.4K |
| MI | 2022-02-23 | 2022-02-22 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $49.10 | -10.0K | 162.9K | -6% | -$491.0K |
| DMI | 2022-02-14 | 2022-02-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $53.50 | -10.0K | 177.6K | -5% | -$535.0K |
| DM | 2022-02-14 | 2022-02-14 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $50.26 | -4,688 | 767.2K | -0.6% | -$235.6K |
| D | 2022-02-14 | 2022-02-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | A - Grant | $0.00 | +22.5K | 768.8K | +3% | $0 |
| MI | 2022-01-20 | 2022-01-20 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $59.99 | -10.0K | 187.2K | -5% | -$599.9K |
| 2022-01-11 | 2021-12-30 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | G - Gift | $0.00 | -8,750 | 746.3K | -1% | $0 | |
| MI | 2022-01-11 | 2022-01-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $68.41 | -10.0K | 190.0K | -5% | -$684.1K |
| MI | 2021-12-21 | 2021-12-20 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $79.24 | -10.0K | 200.0K | -5% | -$792.4K |
| MI | 2021-12-13 | 2021-12-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $71.71 | -10.0K | 219.6K | -4% | -$717.1K |
| I | 2021-11-23 | 2021-11-22 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $75.99 | -10.0K | 220.0K | -4% | -$759.9K |
| I | 2021-11-12 | 2021-11-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $78.15 | -10.0K | 230.0K | -4% | -$781.5K |
| I | 2021-11-12 | 2021-11-09 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | G - Gift | $0.00 | +240.0K | 240.0K | New | $0 |
| 2021-11-12 | 2021-11-09 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | G - Gift | $0.00 | -240.0K | 755.1K | -24% | $0 | |
| MI | 2021-10-04 | 2021-10-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $66.14 | -8,420 | 204 | -98% | -$556.9K |
| 2021-10-04 | 2021-09-24 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | G - Gift | $0.00 | -350 | 995.1K | -0.0% | $0 | |
| I | 2021-10-04 | 2021-09-24 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | G - Gift | $0.00 | +350 | 350 | New | $0 |
| MI | 2021-09-02 | 2021-09-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $67.50 | -8,420 | 8,820 | -49% | -$568.3K |
| MI | 2021-08-03 | 2021-08-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $51.05 | -8,420 | 16.8K | -33% | -$429.8K |
| M | 2021-07-08 | 2021-07-06+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $46.94 | -24.8K | 1.01M | -2% | -$1.16M |
| MI | 2021-07-06 | 2021-07-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bunker Kevin D. | COO | S - Sale | $51.23 | -8,420 | 27.2K | -24% | -$431.3K |
Purchase Sale Sale after option exercise All abbreviations